Evaluation of the effect of nebulised Furosemide on acute dyspnea

Phase 3

Recruiting

• Conditions: R06.0; Acute dyspnea.; Dyspnea

• Registration Number: IRCT20151003024317N12
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Acute dyspnea
Patient transfer by pre-hospital emergency
patients over 18 years old

Exclusion Criteria

patients over 75 years old
Patients require mechanical ventilation
Loss of consciousness
Accompanied by another disease that requires treatment in the first 10 minutes of treatment with digoxin, beta-blocker, beta-agonist and calcium blocker
Need another inhalation treatment in the first 10 minutes
Need non-invasive positive pressure ventilation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acute dyspnea. Timepoint: Before intervention, thirty minutes after intervention. Method of measurement: Shortness of breath chart.;Percentage of oxygen saturation. Timepoint: Before intervention, thirty minutes after intervention. Method of measurement: Percentage of oxygen saturation.

Secondary Outcome Measures

Name	Time	Method
Heart rate. Timepoint: Before intervention, thirty minutes after intervention. Method of measurement: Based on the information recorded in patient's record.;Number of breaths. Timepoint: Before intervention, thirty minutes after intervention. Method of measurement: Based on the information recorded in patient's record.